Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-82540

Xenbase Image ID: 82540


Fig. 5. Expression of human and mouse LIN-28 in cultured cells, embryos, and tissues. (A) Immunoblot of cultured mouse and human cell lines using antiserum raised against full-length recombinant human LIN-28 protein. ES fb, mouse embryonic stem cells with mouse fibroblast feeder cells; fb, mouse fibroblasts alone; MRC-5, human fetal lung fibroblast; HeLa, human cervical adenocarcinoma; HL-60, human promyelocytic leukemia; MCF7, human breast adenocarcinoma; A2780, human ovarian adenocarcinoma; NT2, human embryonal carcinoma; NT2N, neurons from retinoic acid-treated NT2 cells. Immunoblot using anti-LIN-28 antisera of cultured cells, embryos and tissues. F9, mouse embryonal carcinoma; P19, mouse embryonal carcinoma; PA-1, human teratocarcinoma; PC-12, rat adrenal pheochromocytoma; 9.5d, 10.5d, 12.5d, mouse embryos at 9.5, 10.5, and 12.5 days postcoitum, respectively; neuron, mouse primary hippocampal neurons; liver, liver from 3- to 4-month-old mice. All samples were normalized for total protein content. Anti-actin was used as a loading control. (B) Micrographs of mouse P19 teratocarcinoma cells stained with anti-LIN-28 antiserum. Left, fluorescence micrograph showing primarily cytoplasmic staining. Right, a DIC image of the same field.

Image published in: Moss EG and Tang L (2003)

Copyright © 2003. Image reproduced with permission of the Publisher, Elsevier B. V.

Larger Image
Printer Friendly View

Return to previous page